| Oral iron use, by DOPPS country and cross-section |
| N Ptnts | Total N | Wgtd % | ||
|---|---|---|---|---|
| DOPPS Country | DOPPS Cross-section | 66 | 506 | 12.4% |
| AusNZ | D2(2002) | |||
| D3(2006) | 32 | 448 | 8.0% | |
| D3(2007) | 39 | 445 | 8.6% | |
| D4(2010) | 2 | 361 | 0.7% | |
| D4(2011) | 4 | 408 | 1.1% | |
| Belgium | D2(2002) | 7 | 534 | 1.3% |
| D3(2006) | 1 | 479 | 0.2% | |
| D3(2007) | 0 | 367 | 0.0% | |
| D4(2010) | 1 | 466 | 0.2% | |
| D4(2011) | 0 | 476 | 0.0% | |
| Canada | D2(2002) | 113 | 576 | 22.4% |
| D3(2006) | 74 | 508 | 20.4% | |
| D3(2007) | 57 | 420 | 21.4% | |
| D4(2010) | 34 | 368 | 13.1% | |
| D4(2011) | 49 | 482 | 14.0% | |
| France | D2(2002) | 9 | 499 | 2.4% |
| D3(2006) | 2 | 540 | 0.4% | |
| D3(2007) | 3 | 539 | 0.5% | |
| D4(2010) | 4 | 367 | 1.5% | |
| D4(2011) | 7 | 502 | 1.8% | |
| Germany | D2(2002) | 7 | 565 | 1.3% |
| D3(2006) | 5 | 555 | 0.8% | |
| D3(2007) | 6 | 606 | 0.9% | |
| D4(2010) | 4 | 646 | 0.5% | |
| D4(2011) | 4 | 668 | 0.5% | |
| Italy | D2(2002) | 10 | 555 | 1.8% |
| D3(2006) | 85 | 500 | 17.4% | |
| D3(2007) | 91 | 506 | 22.1% | |
| D4(2010) | 1 | 580 | 0.1% | |
| D4(2011) | 2 | 603 | 0.2% | |
| Japan | D2(2002) | 51 | 1,720 | 3.0% |
| D3(2006) | 63 | 1,759 | 3.2% | |
| D3(2007) | 61 | 1,783 | 3.1% | |
| D4(2010) | 31 | 1,701 | 1.8% | |
| D4(2011) | 53 | 1,683 | 2.8% | |
| Spain | D2(2002) | 23 | 595 | 3.3% |
| D3(2006) | 10 | 620 | 1.6% | |
| D3(2007) | 9 | 529 | 1.9% | |
| D4(2010) | 0 | 700 | 0.0% | |
| D4(2011) | 0 | 586 | 0.0% | |
| Sweden | D2(2002) | 6 | 545 | 1.0% |
| D3(2006) | 2 | 504 | 0.3% | |
| D3(2007) | 4 | 493 | 1.0% | |
| D4(2010) | 1 | 490 | 0.3% | |
| D4(2011) | 1 | 545 | 0.3% | |
| UK | D2(2002) | 23 | 543 | 4.2% |
| D3(2006) | 9 | 431 | 1.4% | |
| D3(2007) | 8 | 325 | 2.1% | |
| D4(2010) | 3 | 397 | 0.8% | |
| D4(2011) | 2 | 475 | 0.3% | |
| US | D2(2002) | 260 | 2,156 | 12.1% |
| D3(2006) | 69 | 1,735 | 4.7% | |
| D3(2007) | 50 | 1,162 | 4.8% | |
| D4(2010) | 146 | 3,167 | 5.0% | |
| D4(2011) | 206 | 3,600 | 5.5% | |
| Medications reported as prescribed (not necessarily taken) in previous four months, among all patients |
Please see additional methodological information in the Data Sources and Methods section. |